Drug Shortage Report for POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE

Last updated on 2025-05-02 History
Report ID 216966
Drug Identification Number 00402206
Brand name POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE
Common or Proper name Potassium Chloride for Injection Concentrate
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) POTASSIUM CHLORIDE
Strength(s) 20mEq
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 x 20mL, 10 x 10mL
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-06-30
Actual start date
Estimated end date 2025-07-31
Actual end date
Shortage status Anticipated shortage
Updated date 2025-05-02
Company comments We are currently collaborating with Health Canada’s Drug Shortages Unit to mitigate any market impact.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-05-02 French Compare
v5 2025-05-02 English Compare
v4 2025-04-22 English Compare
v3 2025-04-21 French Compare
v2 2025-04-21 English Compare
v1 2024-01-22 English Compare

Showing 1 to 6 of 6